Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-28

Clinical Trial Update: Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of etanercept in hemodialysis patients with end-stage renal disease; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Kaysen, George A., M.D., Ph.D. | Conditions: End Stage Renal Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-05-28